Arrhythmia was defined as the development of a new arrhythmia detected in the procedural period.
The results show that the use of pethidine provided a statistically significant pain relief in the immediate post procedural period in comparison to the placebo group but has not long-term effect.
These time points were selected because they were thought to represent post-procedural periods of relative medical stability.
The findings were presumably due to an embolic event in the peri-procedural period.
Blood pressure control requires careful attention in the peri-procedural period, which can potentially lower the incidence of procedural stroke.
Additional studies are required to establish guidelines for the management of haemodynamic instability in the peri-procedural period.
There was a higher risk of cardiac events in the peri-procedural period in the CKD group but similar rates of stroke and death.
Recent guidelines recommend continuation of aspirin or cilostazol therapy during the peri-procedural period, and do not recommend heparin as a bridge to antiplatelet medication.
These consultations represent opportunities to transiently optimize medications and the management of comorbidities for the peri-procedural period, however, this requires a framework of appropriate characteristics to target.
Routine antibiotic prophylaxis is not recommended in ESPEN artificial enteral nutrition guidelines; prophylaxis was given to 7% of our patients and 55%% of the patients were already on antibiotics during the peri-procedural period.
According to recent guidelines, for those receiving antiplatelet therapy, HBT is not recommended and antiplatelet therapy should be continued with low-dose aspirin during the peri-procedural period [ 2, 3].
